Suppr超能文献

在经支气管超声引导下经支气管针吸活检中使用所谓的组织胶凝块法提高细胞块制备的细胞数量。

Improvement of cellularity on cell block preparations using the so-called tissue coagulum clot method during endobronchial ultrasound-guided transbronchial fine-needle aspiration.

机构信息

Department of Pulmonary and Critical Care Medicine, The Johns Hopkins Medical Institutions, Baltimore 21224, Maryland.

出版信息

Cancer Cytopathol. 2012 Jun 25;120(3):185-95. doi: 10.1002/cncy.20199. Epub 2011 Dec 5.

Abstract

BACKGROUND

Cell block (CB) preparation during the endobronchial ultrasound-guided transbronchial fine-needle aspiration (EBUS-TBNA) procedure plays an important role in the diagnosis of lung cancer and recovery of cellular material for molecular characterization of the tumor. However, the efficiency of the conventional method of CB preparation is suboptimal.

METHODS

In the current study, the "tissue coagulum clot" cell block (TCC-CB) method was used to prepare the CBs and its efficiency was compared with that of the conventional saline rinse cell block (NR-CB) method. A total of 84 consecutive TCC-CBs (106 lymph nodes [LNs] and 14 lung lesions) and 28 consecutive cases of NR-CB (39 LNs and 3 lung lesions) obtained within the same time period were included in the current study.

RESULTS

In the TCC-CB specimens, 94 of 106 LN cases (88.7%) yielded sufficient diagnostic material, as did 11 of 14 lung lesions (78.6%). In the NR-CB group, which was used as the control, 22 of 39 LN specimens (56.4%) and none of 3 lung specimens (0%) were found to provide sufficient diagnostic material. Although the average size of the LNs in the study group were not significantly different from those in the control group (1.76 cm vs 1.82 cm; P > .05), the overall nondiagnostic rates in the TCC-CB and NR-CB groups were 11.2% and 43.6%, respectively (P < .001). The nondiagnostic rates of the lung specimens were 15.4% in the TCC-CB group and 100% in the NR-CB group (P < .05). In addition, immunohistochemistry studies and epidermal growth factor receptor (EGFR)/KRAS mutational analyses were performed in 26 and 14 TCC-CB cases, respectively. With the exception of 1 case, all of them had satisfactory results.

CONCLUSIONS

The data from the current study demonstrate that the TCC-CB method significantly increases the cellular yield of CB preparations without compromising cytomorphological characterization of tumor cells.

摘要

背景

经支气管超声引导针吸活检(EBUS-TBNA)过程中的细胞块(CB)制备对于肺癌的诊断和肿瘤细胞的分子特征恢复具有重要作用。然而,传统的 CB 制备方法的效率并不理想。

方法

在本研究中,使用了“组织凝块细胞块(TCC-CB)”方法来制备 CB,并将其与常规的生理盐水冲洗细胞块(NR-CB)方法的效率进行了比较。共纳入了同期 84 例连续的 TCC-CB(106 个淋巴结[LN]和 14 个肺病变)和 28 例连续的 NR-CB(39 个 LN 和 3 个肺病变)。

结果

在 TCC-CB 标本中,106 个 LN 病例中有 94 例(88.7%)获得了足够的诊断材料,14 个肺病变中有 11 例(78.6%)获得了足够的诊断材料。在 NR-CB 组中,作为对照组,39 个 LN 标本中有 22 个(56.4%)和 3 个肺标本中没有一个(0%)提供了足够的诊断材料。尽管研究组中 LN 的平均大小与对照组无显著差异(1.76cm 比 1.82cm;P>0.05),但 TCC-CB 和 NR-CB 组的总体非诊断率分别为 11.2%和 43.6%(P<0.001)。TCC-CB 组的肺标本非诊断率为 15.4%,NR-CB 组为 100%(P<0.05)。此外,在 26 例 TCC-CB 病例中进行了免疫组织化学研究,在 14 例 TCC-CB 病例中进行了表皮生长因子受体(EGFR)/KRAS 突变分析。除 1 例外,所有病例均取得了满意的结果。

结论

本研究的数据表明,TCC-CB 方法显著提高了 CB 制备的细胞产量,同时不影响肿瘤细胞的细胞形态学特征。

相似文献

4
Endobronchial ultrasound-guided transbronchial needle aspiration in the diagnosis of lung cancer.
Lung Cancer. 2010 Oct;70(1):51-6. doi: 10.1016/j.lungcan.2010.01.008. Epub 2010 Mar 12.
9
Endobronchial ultrasound with transbronchial needle aspiration for restaging the mediastinum in lung cancer.
J Clin Oncol. 2008 Jul 10;26(20):3346-50. doi: 10.1200/JCO.2007.14.9229. Epub 2008 Jun 2.
10
Endobronchial-ultrasound guided miniforceps biopsy of mediastinal and hilar lesions.
Ann Thorac Surg. 2011 Jul;92(1):284-8. doi: 10.1016/j.athoracsur.2011.03.069.

引用本文的文献

1
Contemporary art of cell-block preparation: Overview.
Cytojournal. 2024 Jan 31;21:5. doi: 10.25259/Cytojournal_56_2023. eCollection 2024.
2
Pleural fluid residue as a diagnostic tool for cytology-negative malignant pleural effusion: A proof-of-concept study.
Afr J Thorac Crit Care Med. 2023 Nov 27;29(4):e1149. doi: 10.7196/AJTCCM.2023.v29i4.1149. eCollection 2023.
4
Molecular diagnosis in non-small-cell lung cancer: expert opinion on and testing.
J Clin Pathol. 2022 Mar;75(3):145-153. doi: 10.1136/jclinpath-2021-207490. Epub 2021 Apr 19.
5
Current classification systems and standardized terminology in cytopathology.
Rom J Morphol Embryol. 2020 Jul-Sep;61(3):655-663. doi: 10.47162/RJME.61.3.03.
6
Pathologic interpretation of endoscopic ultrasound-guided fine needle aspiration cytology/biopsy for pancreatic lesions.
J Pathol Transl Med. 2020 Sep;54(5):367-377. doi: 10.4132/jptm.2020.07.21. Epub 2020 Aug 31.

本文引用的文献

1
EGFR and KRAS mutations in metastatic lung adenocarcinomas.
Hum Pathol. 2011 Oct;42(10):1447-53. doi: 10.1016/j.humpath.2010.12.011. Epub 2011 Apr 15.
2
Lung cancer management in 2010.
Oncology (Williston Park). 2011 Jan;25(1):64-73.
3
Global cancer statistics.
CA Cancer J Clin. 2011 Mar-Apr;61(2):69-90. doi: 10.3322/caac.20107. Epub 2011 Feb 4.
4
New driver mutations in non-small-cell lung cancer.
Lancet Oncol. 2011 Feb;12(2):175-80. doi: 10.1016/S1470-2045(10)70087-5.
5
Revolution in lung cancer: new challenges for the surgical pathologist.
Arch Pathol Lab Med. 2011 Jan;135(1):110-6. doi: 10.5858/2010-0567-RA.1.
6
The tissue is the issue: personalized medicine for non-small cell lung cancer.
Clin Cancer Res. 2010 Oct 15;16(20):4909-11. doi: 10.1158/1078-0432.CCR-10-2005. Epub 2010 Oct 5.
8
The mutation spectrum revealed by paired genome sequences from a lung cancer patient.
Nature. 2010 May 27;465(7297):473-7. doi: 10.1038/nature09004.
9
Advances in the diagnosis of lung cancer: contribution of molecular biology to bronchoscopic diagnosis.
Curr Opin Pulm Med. 2010 Jul;16(4):315-20. doi: 10.1097/MCP.0b013e328337f938.
10
A cell-block preparation using glucomannan extracted from Amorphophallus konjac.
Diagn Cytopathol. 2010 Sep;38(9):652-6. doi: 10.1002/dc.21280.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验